News tagged with thyroid cancer
New drug screening identifies chemical agents with potent anti-cancer activity
Drugs already approved for clinical use across a variety of therapeutic categories can be screened to identify effective agents for thyroid cancer according to a recent study accepted for publication in the Endocrine Society's ...
Jan 05, 2012 |
5 / 5 (1) |
0
Cleveland Clinic researcher discovers genetic cause of thyroid cancer
Cleveland Clinic researchers have discovered three genes that increase the risk of thyroid cancer, which is has the largest incidence increase in cancers among both men and women.
Dec 23, 2011 |
not rated yet |
0
Removal of lymph nodes during surgery for thyroid cancer may be beneficial
Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent ...
Dec 20, 2011 |
not rated yet |
0
|
BRAF addiction of thyroid cancers makes them therapeutically vulnerable
Papillary carcinoma is the most common form of thyroid cancer. Approximately one quarter of these carcinomas have mutations in the BRAF gene. The prevalence of such mutations is even greater in high-grade carcinomas, particularly ...
Nov 21, 2011 |
not rated yet |
0
Technology makes storing radioactive waste safer
(PhysOrg.com) -- Queensland University of Technology (QUT) researchers have developed new technology capable of removing radioactive material from contaminated water and aiding clean-up efforts following nuclear ...
Oct 31, 2011 |
4.5 / 5 (6) |
0
Antineoplastic agents associated with thyroid dysfunction
Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can ...
Oct 18, 2011 |
not rated yet |
0
Study suggests possible link between two Type 2 diabetes drugs and pancreatic cancer
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according ...
Medicine & Health / Medications
Sep 16, 2011 |
5 / 5 (3) |
0
|
Pituitary hormone TSH found to directly influence bone growth
Researchers at Mount Sinai School of Medicine have found that thyroid-stimulating hormone (TSH), a hormone produced in the anterior pituitary gland that regulates endocrine function in the thyroid gland, can promote bone ...
Sep 13, 2011 |
5 / 5 (2) |
0
|
Proteins could help women avoid thyroid surgery
Dr. Paul Weinberger wants to make thyroid cancer diagnosis as simple and accurate as checking for high cholesterol.
Sep 12, 2011 |
not rated yet |
0
|
Thyroid cancer treatment varies by hospital, study finds
Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.
Aug 16, 2011 |
not rated yet |
0
New approach to thyroid surgery eliminates neck scar
As the rate of thyroid cancer continues to climb, doctors are urging patients to be more cautious about thyroid nodules, a common disorder that is responsible for a small but growing number of thyroid cancer cases. Thyroid ...
Aug 09, 2011 |
not rated yet |
0
African-Americans with thyroid cancer fare worse than whites
African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis -- and are more likely to die from it, according to a new study.
Jun 21, 2011 |
not rated yet |
0
Hypnosis/local anesthesia combination during surgery helps patients, reduces hospital stays
Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also ...
Jun 11, 2011 |
5 / 5 (1) |
0
High-impact radiopeptide therapy halts neuroendocrine cancer
Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. ...
Jun 06, 2011 |
5 / 5 (1) |
0
Fighting cancer with cancer: Mayo Clinic finds promising use for thyroid cancer gene
A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found.
Jun 04, 2011 |
not rated yet |
0
|
Thyroid neoplasm
Thyroid neoplasm or thyroid cancer usually refers to any of four kinds of malignant tumors of the thyroid gland: papillary, follicular, medullary or anaplastic. Most patients are 25 to 65 years of age when first diagnosed; women are more affected than men. Papillary and follicular tumors are the most common. They grow slowly and may recur, but are generally not fatal in patients under 45 years of age. Medullary tumors have a good prognosis if restricted to the thyroid gland and a poorer prognosis if metastasis occurs. Anaplastic tumors are fast-growing and respond poorly to therapy.
Thyroid nodules are diagnosed by ultrasound guided fine needle aspiration (USG/FNA) or frequently by thyroidectomy (surgical removal and subsequent histological examination). As thyroid cancer can take up iodine, radioactive iodine is commonly used to treat thyroid carcinomas, followed by TSH suppression by high-dose thyroxine therapy.
For more information about Thyroid neoplasm, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
